AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9695205 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine solution rinsing 4 times daily
Number of subjects: 40
Study 9695205 — intervention group
Group type: COMPARATOR
Intervention: Sterile water rinsing (Control)
Number of subjects: 40
Study 8122604 — intervention group
Group type: EXPERIMENTAL
Intervention: dl-sotalol 80 mg/day
Number of subjects: 60
Study 8122604 — intervention group
Group type: EXPERIMENTAL
Intervention: dl-sotalol 160 mg/day
Number of subjects: 60
Study 8122604 — intervention group
Group type: COMPARATOR
Intervention: digoxin monotherapy (placebo)
Number of subjects: 60
Study 2486654 — intervention group
Group type: COMPARATOR
Intervention: Morphine hydrochloride (50 micrograms/kg)
Number of subjects: 40
Study 2486654 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine hydrochloride (3 micrograms/kg)
Number of subjects: 40
Study 700598 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride (oral application)
Number of subjects: 0
Study 700598 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride (parenteral application)
Number of subjects: 0
Study 31773776 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin treatment
Number of subjects: 4
Study 31773776 — intervention group
Group type: COMPARATOR
Intervention: Rotenone-exposed
Number of subjects: 4
Study 31773776 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotenone + Melatonin
Number of subjects: 4
Study 31773776 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 4
Study 31699751 — intervention group
Group type: EXPERIMENTAL
Intervention: Study-approved lotion
Number of subjects: 520
Study 31699751 — intervention group
Group type: EXPERIMENTAL
Intervention: Study-approved cream
Number of subjects: 520
Study 31699751 — intervention group
Group type: EXPERIMENTAL
Intervention: Study-approved gel
Number of subjects: 520
Study 31699751 — intervention group
Group type: EXPERIMENTAL
Intervention: Study-approved ointment
Number of subjects: 520
Study 31699751 — intervention group
Group type: COMPARATOR
Intervention: Standard care (topical corticosteroids)
Number of subjects: 520
Study 31699751 — intervention group
Group type: EXPERIMENTAL
Intervention: Eczema signs (Eczema Area Severity Index) by masked researcher
Number of subjects: 520
Study 31699751 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment use
Number of subjects: 520
Study 31699751 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent satisfaction
Number of subjects: 520
Study 31699751 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 520
Study 31699751 — intervention group
Group type: EXPERIMENTAL
Intervention: Child and family quality of life (Atopic Dermatitis Quality of Life, Child Health Utility 9D and Dermatitis Family Impact)
Number of subjects: 520
Study 28076735 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication management plans completed by a pharmacist (intervention)
Number of subjects: 832
Study 28076735 — intervention group
Group type: COMPARATOR
Intervention: Standard medical discharge summaries (control)
Number of subjects: 832
Study 25817213 — intervention group
Group type: EXPERIMENTAL
Intervention: Endodontic treatment and scaling and root planning (SRP) performed simultaneously
Number of subjects: 31
Study 25817213 — intervention group
Group type: COMPARATOR
Intervention: SRP performed 3 months after endodontic treatment
Number of subjects: 31
Study 23980077 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX4
Number of subjects: 371
Study 23980077 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 371
Study 21613350 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-h GH infusion (0.2-0.3 mg in total) that terminated 5 h before the clamp (study 1)
Number of subjects: 8
Study 21613350 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-h GH infusion timed to continue during the first hour of the clamp (study 2)
Number of subjects: 8
Study 21613350 — intervention group
Group type: EXPERIMENTAL
Intervention: No GH (study 0)
Number of subjects: 8
Study 21613350 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy untreated subjects)
Number of subjects: 8
Study 19357559 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab injection after cataract surgery
Number of subjects: 26
Study 19357559 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution injection (Control)
Number of subjects: 26
Study 17110056 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive computer-assisted instruction program
Number of subjects: 344
Study 17110056 — intervention group
Group type: COMPARATOR
Intervention: Culturally appropriate video
Number of subjects: 344
Study 17110056 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet only
Number of subjects: 344
Study 17110056 — intervention group
Group type: COMPARATOR
Intervention: Non-interactive group (pamphlet and video combined)
Number of subjects: 344
Study 15501376 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced version of usually provided services
Number of subjects: 179
Study 15501376 — intervention group
Group type: COMPARATOR
Intervention: Usually provided services
Number of subjects: 179
Study 11707669 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir DF plus Hydroxyurea (500 mg bid for 28 days)
Number of subjects: 28
Study 11707669 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir DF (75 mg once daily for 28 days)
Number of subjects: 28
Study 11707669 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir placebo
Number of subjects: 28
Study 9140907 — intervention group
Group type: EXPERIMENTAL
Intervention: Steady-state exercise (150 min at 58% of PPO)
Number of subjects: 6
Study 9140907 — intervention group
Group type: COMPARATOR
Intervention: Stochastic exercise (150 min at 58 +/- 12.2% of PPO)
Number of subjects: 6
Study 8198302 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 1%
Number of subjects: 24
Study 8198302 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine 2%
Number of subjects: 24
Study 8198302 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 1%
Number of subjects: 24
Study 8198302 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 24
Study 3805550 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 18
Study 3805550 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Theophylline and Albuterol
Number of subjects: 18
Study 3805550 — intervention group
Group type: COMPARATOR
Intervention: Albuterol
Number of subjects: 18
Study 31505955 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard palate closure at age 12 months
Number of subjects: 125
Study 31505955 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard palate closure at age 36 months
Number of subjects: 125
Study 31505955 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior cleft width
Number of subjects: 125
Study 31505955 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleft size at tuberosity level
Number of subjects: 125
Study 31505955 — intervention group
Group type: EXPERIMENTAL
Intervention: Anteroposterior palatal length
Number of subjects: 125
Study 31505955 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled scores VPC-Pooled
Number of subjects: 125
Study 31505955 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichotomic scores VPC-Dichotomic
Number of subjects: 125
Study 29471763 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral HIV/STI intervention (Women on the Road to Health [WORTH])
Number of subjects: 333
Study 27776678 — intervention group
Group type: EXPERIMENTAL
Intervention: PM plus cognitive behavioral therapy (CBT)
Number of subjects: 140
Study 27776678 — intervention group
Group type: COMPARATOR
Intervention: PM only
Number of subjects: 140
Study 24684603 — intervention group
Group type: EXPERIMENTAL
Intervention: ta‐VNS
Number of subjects: 144
Study 24684603 — intervention group
Group type: COMPARATOR
Intervention: tn‐VNS
Number of subjects: 144
Study 23789813 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus saline injection with arm elevation
Number of subjects: 30
Study 23789813 — intervention group
Group type: COMPARATOR
Intervention: Control group (no saline injection)
Number of subjects: 30
Study 20463310 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper punctal occlusion
Number of subjects: 40
Study 20463310 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower punctal occlusion
Number of subjects: 40
Study 20463310 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 40
Study 18249220 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary glycemic index (GI)
Number of subjects: 18137
Study 18249220 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary glycemic load (GL)
Number of subjects: 18137
Study 16774830 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal hyperbaric bupivacaine 3.75 mg
Number of subjects: 44
Study 16774830 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal hyperbaric bupivacaine 9 mg
Number of subjects: 44
Study 14516015 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions for HIV prevention
Number of subjects: 0
Study 14516015 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental interventions
Number of subjects: 0
Study 14516015 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions
Number of subjects: 0
Study 14516015 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental studies
Number of subjects: 0
Study 14516015 — intervention group
Group type: EXPERIMENTAL
Intervention: New program of research
Number of subjects: 0
Study 14516015 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trials
Number of subjects: 0
Study 11206018 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine invasive strategy (cardiac catheterization followed by percutaneous coronary intervention within 24 hours of onset of angina)
Number of subjects: 0
Study 11206018 — intervention group
Group type: COMPARATOR
Intervention: Conservative (ischemia-guided) strategy with aggressive medical therapy
Number of subjects: 0
Study 11206018 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (intensive antiplatelet, antithrombotic, and anti-ischemic therapy)
Number of subjects: 0
Study 8632538 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 instillation of mitomycin C (40 mg/40 ml water)
Number of subjects: 502
Study 8632538 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 instillations of mitomycin C (40 mg/40 ml water)
Number of subjects: 502
Study 8632538 — intervention group
Group type: COMPARATOR
Intervention: No further treatment
Number of subjects: 502
Study 1626676 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural catheter migration
Number of subjects: 153
Study 2860183 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical povidone-iodine (PVP-I)
Number of subjects: 100
Study 2860183 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 100
Study 28956139 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliced soaked almonds
Number of subjects: 76
Study 28956139 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliced unsoaked almonds
Number of subjects: 76
Study 28956139 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole soaked almonds
Number of subjects: 76
Study 28956139 — intervention group
Group type: COMPARATOR
Intervention: Whole unsoaked almonds
Number of subjects: 76
Study 26681495 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene loci associated with schizophrenia
Number of subjects: 0
Study 26681495 — intervention group
Group type: EXPERIMENTAL
Intervention: Variants in brain-related genes with low NSS score
Number of subjects: 0
Study 26681495 — intervention group
Group type: EXPERIMENTAL
Intervention: Candidate schizophrenia susceptibility loci
Number of subjects: 0
Study 25518875 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine podiatry care and a falls prevention leaflet
Number of subjects: 2600
Study 25518875 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine podiatry care, a falls prevention leaflet, and a multifaceted podiatry intervention
Number of subjects: 2600
Study 21802253 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior approach with posterior soft tissue repair
Number of subjects: 196
Study 21802253 — intervention group
Group type: COMPARATOR
Intervention: Lateral approach
Number of subjects: 196
Study 21802253 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 196
Study 20436703 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem high-dose chemotherapy and autologous stem cell rescue (HDCT/ASCR)
Number of subjects: 141
Study 20436703 — intervention group
Group type: COMPARATOR
Intervention: Single high-dose chemotherapy and autologous stem cell rescue (HDCT/ASCR)
Number of subjects: 141
Study 17708780 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS over left dorsolateral prefrontal cortex (DLPFC) (5 Hz rTMS; 120% motor threshold) with placebo pill
Number of subjects: 21
Study 17708780 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS with fluoxetine 20 mg/d
Number of subjects: 21
Study 18391714 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitra-HABg
Number of subjects: 24
Study 18391714 — intervention group
Group type: COMPARATOR
Intervention: Autogenous graft
Number of subjects: 24
Study 15209326 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness-and-health magazine exposure
Number of subjects: 90
Study 15209326 — intervention group
Group type: COMPARATOR
Intervention: Fashion magazine exposure
Number of subjects: 90
Study 15209326 — intervention group
Group type: COMPARATOR
Intervention: News magazine exposure
Number of subjects: 90
Study 11401114 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 50 mg daily
Number of subjects: 28
Study 11401114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 9431896 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐IFN 2a, 3 MU, three times weekly for 12 months
Number of subjects: 90
Study 8324675 — intervention group
Group type: EXPERIMENTAL
Intervention: Early appendectomy (group B)
Number of subjects: 56
Study 8324675 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (group A)
Number of subjects: 56
Study 2948451 — intervention group
Group type: EXPERIMENTAL
Intervention: Etretin therapy (50 mg/d)
Number of subjects: 21
Study 2948451 — intervention group
Group type: EXPERIMENTAL
Intervention: Etretin therapy
Number of subjects: 21
Study 2948451 — intervention group
Group type: EXPERIMENTAL
Intervention: Etretin therapy for six or more months
Number of subjects: 21
Study 31969168 — intervention group
Group type: EXPERIMENTAL
Intervention: French lyophilized plasma (FLYP)
Number of subjects: 140
Study 31969168 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 140
Study 31573942 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation combining sound and electrical somatosensory stimulation of the tongue for 12 weeks
Number of subjects: 192
Study 31573942 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation with different stimulation settings over 12 weeks
Number of subjects: 192
Study 31573942 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation with stratification for hyperacusis and high tinnitus symptom severity
Number of subjects: 192
Study 31573942 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimodal neuromodulation with a CE-marked device
Number of subjects: 192
Study 28284927 — intervention group
Group type: EXPERIMENTAL
Intervention: Apneic oxygenation
Number of subjects: 24
Study 28284927 — intervention group
Group type: COMPARATOR
Intervention: Low-tidal-volume ventilation
Number of subjects: 24
Study 25105832 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiband (MB) gradient‐echo echo planar imaging (GE‐EPI) with two-fold slice acceleration (MB2)
Number of subjects: 0
Study 25105832 — intervention group
Group type: COMPARATOR
Intervention: Standard GE‐EPI (MB1)
Number of subjects: 0
Study 23683002 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 2330
Study 23683002 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 2330
Study 21299313 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach training to conceptually approach Blacks
Number of subjects: 0
Study 19815635 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks
Number of subjects: 122
Study 19815635 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 122
Study 16937281 — intervention group
Group type: EXPERIMENTAL
Intervention: Beating heart (off-pump)
Number of subjects: 25
Study 16937281 — intervention group
Group type: COMPARATOR
Intervention: Cardiopulmonary bypass with warm cardioplegia
Number of subjects: 25
Study 16937281 — intervention group
Group type: COMPARATOR
Intervention: Cardiopulmonary bypass with cold cardioplegia
Number of subjects: 25
Study 16937281 — intervention group
Group type: COMPARATOR
Intervention: Cardiopulmonary bypass (both warm and cold)
Number of subjects: 25
Study 15283938 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg daily)
Number of subjects: 42
Study 15283938 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hormone replacement therapy (0.625 mg conjugated equine estrogens + 5 mg medroxyprogesterone daily)
Number of subjects: 42
Study 15283938 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy (50 microg estradiol + 5 mg medroxyprogesterone daily)
Number of subjects: 42
Study 15283938 — intervention group
Group type: COMPARATOR
Intervention: All groups (Tibolone and both hormone replacement therapies)
Number of subjects: 42
Study 11828945 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 and Carboplatin AUC 7
Number of subjects: 0
Study 11828945 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 160 mg/m2 and Carboplatin AUC 6
Number of subjects: 0
Study 11828945 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 and Carboplatin AUC 6
Number of subjects: 0
Study 11828945 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor (G-CSF)
Number of subjects: 0
Study 9016011 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategies to increase patient control of visiting
Number of subjects: 0
Study 8279246 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol/alfentanil anaesthesia
Number of subjects: 86
Study 8279246 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone/halothane anaesthesia
Number of subjects: 86
Study 8279246 — intervention group
Group type: EXPERIMENTAL
Intervention: Both anaesthesia methods
Number of subjects: 86
Study 3033389 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg bid for 8 days on a 50 mmol sodium diet
Number of subjects: 9
Study 3033389 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg bid for 8 days on a 200 mmol sodium diet
Number of subjects: 9
Study 3033389 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mmol sodium diet
Number of subjects: 9
Study 3033389 — intervention group
Group type: COMPARATOR
Intervention: 200 mmol sodium diet
Number of subjects: 9
Study 31982219 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth to Mouth ventilation (MM-only) at 5 kn
Number of subjects: 13
Study 31982219 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth to Mouth ventilation (MM-only) at 10 kn
Number of subjects: 13
Study 31982219 — intervention group
Group type: EXPERIMENTAL
Intervention: Full CPR at 5 kn
Number of subjects: 13
Study 31982219 — intervention group
Group type: EXPERIMENTAL
Intervention: Full CPR at 10 kn
Number of subjects: 13
Study 31982219 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of MM at 5 kn
Number of subjects: 13
Study 31982219 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of MM at 10 kn
Number of subjects: 13
Study 31982219 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of CPR at 5 kn
Number of subjects: 13
Study 31982219 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of CPR at 10 kn
Number of subjects: 13
Study 31982219 — intervention group
Group type: COMPARATOR
Intervention: Resuscitation on RWC
Number of subjects: 13
Study 30501828 — intervention group
Group type: EXPERIMENTAL
Intervention: Panretinal photocoagulation (PRP) plus intravitreal bevacizumab (IVB)
Number of subjects: 60
Study 30501828 — intervention group
Group type: COMPARATOR
Intervention: Panretinal photocoagulation (PRP) alone
Number of subjects: 60
Study 27603354 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinus tarsi approach
Number of subjects: 64
Study 27603354 — intervention group
Group type: COMPARATOR
Intervention: Extended lateral approach
Number of subjects: 64
Study 24749779 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral economic measures of alcohol reward value (demand persistence and amplitude of demand)
Number of subjects: 207
Study 24749779 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral economic indices of reward value
Number of subjects: 207
Study 22581278 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-form Tai chi
Number of subjects: 101
Study 22581278 — intervention group
Group type: COMPARATOR
Intervention: Education control
Number of subjects: 101
Study 20079596 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 1800
Study 20079596 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 1800
Study 18575157 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg, 40 mg-80 mg)
Number of subjects: 83
Study 17477207 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice photographs with anticipated important choice
Number of subjects: 0
Study 17477207 — intervention group
Group type: COMPARATOR
Intervention: Choice photographs with anticipated unimportant choice
Number of subjects: 0
Study 17477207 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice photographs with caffeine arousal
Number of subjects: 0
Study 17477207 — intervention group
Group type: COMPARATOR
Intervention: Choice photographs with informed arousal source
Number of subjects: 0
Study 17477207 — intervention group
Group type: COMPARATOR
Intervention: Choice photographs with no arousal
Number of subjects: 0
Study 11345494 — intervention group
Group type: EXPERIMENTAL
Intervention: Curved cane
Number of subjects: 18
Study 11345494 — intervention group
Group type: COMPARATOR
Intervention: Traditional straight long cane
Number of subjects: 18